Intention-to-Treat in Randomized Controlled Trials: Recommendations for a Total Trial Strategy

被引:84
|
作者
Polit, Denise F. [1 ,2 ]
Gillespie, Brigid M. [2 ]
机构
[1] Humanalysis Inc, Saratoga Springs, NY USA
[2] Griffith Univ, Res Ctr Clin & Community Practice Innovat, Gold Coast, Qld, Australia
关键词
data analysis; statistical; intention-to-treat analysis; missing data; randomized controlled trials; nursing; MISSING DATA; MULTIPLE IMPUTATION; CLINICAL-TRIALS; RETENTION; PARTICIPANTS; RECRUITMENT; EXCLUSIONS; PROTOCOL; LOST; BIAS;
D O I
10.1002/nur.20386
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Intention-to-treat (ITT) in randomized controlled trials involves keeping participants in the treatment groups to which they were randomized regardless of whether they withdraw following randomization. Intention-to-treat is a strategy for maintaining the integrity of randomization and strengthening the trial's internal validity. Although ITT is advocated by the Consolidated Standards of Reporting Trials (CONSORT) guidelines, there is confusion about what ITT means and little specific advice on how to achieve it. The purpose of this article is to present definitions of ITT and to suggest strategies for implementing ITT as a total design strategy in nursing clinical trials. Recommendations are offered regarding study planning, study design, subject retention, sampling, data collection, data analysis, and reporting within the context of ITT. (C) 2010 Wiley Periodicals, Inc. Res Nurs Health 33:355-368, 2010
引用
收藏
页码:355 / 368
页数:14
相关论文
共 50 条
  • [11] The Use of the Intention-to-Treat Principle in Nursing Clinical Trials
    Polit, Denise F.
    Gillespie, Brigid M.
    NURSING RESEARCH, 2009, 58 (06) : 391 - 399
  • [12] Per-Protocol Versus Intention-to-Treat in Clinical Trials: The Example of GLOBAL-LEADERS Trial
    Santos-Gallego, Carlos G.
    Requena-Ibanez, Juan Antonio
    Badimon, Juan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (10):
  • [13] 'Intention-to-treat' meets 'missing data': implications of alternate strategies for analyzing clinical trials data
    Nich, C
    Carroll, KM
    DRUG AND ALCOHOL DEPENDENCE, 2002, 68 (02) : 121 - 130
  • [14] Randomised controlled trials and clinical maternity care: moving on from intention-to-treat and other simplistic analyses of efficacy
    Welsh, A. W.
    BMC PREGNANCY AND CHILDBIRTH, 2013, 13
  • [15] Future Directions in Clinical Trials and Intention-To-Treat Analysis: Fulfilling Admirable Intentions Through the Right Questions
    Silverman, Wendy K.
    Pettit, Jeremy W.
    Jaccard, James
    JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, 2024, 53 (05) : 840 - 848
  • [16] Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
    Deng, Lejun
    Hsu, Chih-Yuan
    Shyr, Yu
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [17] Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
    Lejun Deng
    Chih-Yuan Hsu
    Yu Shyr
    BMC Medical Research Methodology, 23
  • [18] Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial
    Tillmann, HC
    Sharpe, N
    Sponer, G
    Wehling, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (05) : 205 - 212
  • [19] OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis
    Losina, E.
    Ranstam, J.
    Collins, J. E.
    Schnitzer, T. J.
    Katz, J. N.
    OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (05) : 677 - 685
  • [20] Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle
    Browne, Lois H.
    Graham, Peter H.
    CLINICAL TRIALS, 2014, 11 (06) : 629 - 634